• レポートコード:QYR9N7317 • 出版社/出版日:QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、101ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療・製薬・バイオ |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、ヒト胚性幹細胞(hESC)のグローバル市場について調査・分析したレポートで、種類別(全能性幹細胞、多能性幹細胞、単能性幹細胞)、用途別(研究、臨床試験、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。 ・ヒト胚性幹細胞(hESC)の世界市場規模 ・主要企業別市場シェア ・ヒト胚性幹細胞(hESC)の世界市場規模:種類別(全能性幹細胞、多能性幹細胞、単能性幹細胞) ・ヒト胚性幹細胞(hESC)の世界市場規模:用途別(研究、臨床試験、その他) ・ヒト胚性幹細胞(hESC)のアメリカ市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)のヨーロッパ市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)の中国市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)の日本市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)の東南アジア市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)のインド市場規模(種類別、用途別) ・ヒト胚性幹細胞(hESC)の中南米市場規模(種類別、用途別) ・主要企業別分析(企業概要、製品動向、販売量など) ・ヒト胚性幹細胞(hESC)の世界市場予測(2019年-2025年) ・ヒト胚性幹細胞(hESC)の地域別市場予測(2019年-2025年) ... |
Human embryonic stem cell research has emerged as an importantplatform for the understanding and treatment of pediatric diseases.
From its inception, however, it has raised ethical concerns based
not on the use of stem cells themselves but on objections to the source
of the cells—specifically, the destruction of preimplantation human
embryos. Despite differences in public opinion on this issue, a large
majority of the public supports continued research using embryonic
stem cells.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
In 2018, the global Human Embryonic Stem Cell (hESC) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.
The key players covered in this study
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)
Market segment by Type, the product can be split into
Totipotent Stem Cell
Pluripotent Stem Cell
Unipotent Stem Cell
Market segment by Application, split into
Research
Clinical Trials
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Human Embryonic Stem Cell (hESC) status, future forecast, growth opportunity, key market and key players.
To present the Human Embryonic Stem Cell (hESC) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Human Embryonic Stem Cell (hESC) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Embryonic Stem Cell (hESC) Market Size Growth Rate by Type (2014-2025)
1.4.2 Totipotent Stem Cell
1.4.3 Pluripotent Stem Cell
1.4.4 Unipotent Stem Cell
1.5 Market by Application
1.5.1 Global Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2025)
1.5.2 Research
1.5.3 Clinical Trials
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Human Embryonic Stem Cell (hESC) Market Size
2.2 Human Embryonic Stem Cell (hESC) Growth Trends by Regions
2.2.1 Human Embryonic Stem Cell (hESC) Market Size by Regions (2014-2025)
2.2.2 Human Embryonic Stem Cell (hESC) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Human Embryonic Stem Cell (hESC) Market Size by Manufacturers
3.1.1 Global Human Embryonic Stem Cell (hESC) Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Embryonic Stem Cell (hESC) Market Concentration Ratio (CR5 and HHI)
3.2 Human Embryonic Stem Cell (hESC) Key Players Head office and Area Served
3.3 Key Players Human Embryonic Stem Cell (hESC) Product/Solution/Service
3.4 Date of Enter into Human Embryonic Stem Cell (hESC) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019)
4.2 Global Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019)
5 United States
5.1 United States Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
5.2 Human Embryonic Stem Cell (hESC) Key Players in United States
5.3 United States Human Embryonic Stem Cell (hESC) Market Size by Type
5.4 United States Human Embryonic Stem Cell (hESC) Market Size by Application
6 Europe
6.1 Europe Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
6.2 Human Embryonic Stem Cell (hESC) Key Players in Europe
6.3 Europe Human Embryonic Stem Cell (hESC) Market Size by Type
6.4 Europe Human Embryonic Stem Cell (hESC) Market Size by Application
7 China
7.1 China Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
7.2 Human Embryonic Stem Cell (hESC) Key Players in China
7.3 China Human Embryonic Stem Cell (hESC) Market Size by Type
7.4 China Human Embryonic Stem Cell (hESC) Market Size by Application
8 Japan
8.1 Japan Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
8.2 Human Embryonic Stem Cell (hESC) Key Players in Japan
8.3 Japan Human Embryonic Stem Cell (hESC) Market Size by Type
8.4 Japan Human Embryonic Stem Cell (hESC) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
9.2 Human Embryonic Stem Cell (hESC) Key Players in Southeast Asia
9.3 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Type
9.4 Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Application
10 India
10.1 India Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
10.2 Human Embryonic Stem Cell (hESC) Key Players in India
10.3 India Human Embryonic Stem Cell (hESC) Market Size by Type
10.4 India Human Embryonic Stem Cell (hESC) Market Size by Application
11 Central & South America
11.1 Central & South America Human Embryonic Stem Cell (hESC) Market Size (2014-2019)
11.2 Human Embryonic Stem Cell (hESC) Key Players in Central & South America
11.3 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Type
11.4 Central & South America Human Embryonic Stem Cell (hESC) Market Size by Application
12 International Players Profiles
12.1 Astellas Institute of Regenerative Medicine (US)
12.1.1 Astellas Institute of Regenerative Medicine (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Embryonic Stem Cell (hESC) Introduction
12.1.4 Astellas Institute of Regenerative Medicine (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.1.5 Astellas Institute of Regenerative Medicine (US) Recent Development
12.2 Asterias Biotherapeutics, Inc. (US)
12.2.1 Asterias Biotherapeutics, Inc. (US) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Embryonic Stem Cell (hESC) Introduction
12.2.4 Asterias Biotherapeutics, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.2.5 Asterias Biotherapeutics, Inc. (US) Recent Development
12.3 BD Biosciences (US)
12.3.1 BD Biosciences (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Embryonic Stem Cell (hESC) Introduction
12.3.4 BD Biosciences (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.3.5 BD Biosciences (US) Recent Development
12.4 Cell Cure Neurosciences Ltd. (Israel)
12.4.1 Cell Cure Neurosciences Ltd. (Israel) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Embryonic Stem Cell (hESC) Introduction
12.4.4 Cell Cure Neurosciences Ltd. (Israel) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.4.5 Cell Cure Neurosciences Ltd. (Israel) Recent Development
12.5 Cellular Dynamics International (US)
12.5.1 Cellular Dynamics International (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Embryonic Stem Cell (hESC) Introduction
12.5.4 Cellular Dynamics International (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.5.5 Cellular Dynamics International (US) Recent Development
12.6 GE Healthcare (UK)
12.6.1 GE Healthcare (UK) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Embryonic Stem Cell (hESC) Introduction
12.6.4 GE Healthcare (UK) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.6.5 GE Healthcare (UK) Recent Development
12.7 MilliporeSigma (US)
12.7.1 MilliporeSigma (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Embryonic Stem Cell (hESC) Introduction
12.7.4 MilliporeSigma (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.7.5 MilliporeSigma (US) Recent Development
12.8 PerkinElmer, Inc. (US)
12.8.1 PerkinElmer, Inc. (US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human Embryonic Stem Cell (hESC) Introduction
12.8.4 PerkinElmer, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.8.5 PerkinElmer, Inc. (US) Recent Development
12.9 Reliance Life Sciences Ltd. (India)
12.9.1 Reliance Life Sciences Ltd. (India) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Human Embryonic Stem Cell (hESC) Introduction
12.9.4 Reliance Life Sciences Ltd. (India) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.9.5 Reliance Life Sciences Ltd. (India) Recent Development
12.10 Research & Diagnostics Systems, Inc. (US)
12.10.1 Research & Diagnostics Systems, Inc. (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Human Embryonic Stem Cell (hESC) Introduction
12.10.4 Research & Diagnostics Systems, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)
12.10.5 Research & Diagnostics Systems, Inc. (US) Recent Development
12.11 SABiosciences Corp. (US)
12.12 STEMCELL Technologies, Inc. (Canada)
12.13 Stemina Biomarker Discovery, Inc. (US)
12.14 Takara Bio, Inc. (Japan)
12.15 TATAA Biocenter AB (Sweden)
12.16 Thermo Fisher Scientific, Inc. (US)
12.17 UK Stem Cell Bank (UK)
12.18 ViaCyte, Inc. (US)
12.19 Vitrolife AB (Sweden)
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Human Embryonic Stem Cell (hESC) Key Market Segments
Table Key Players Human Embryonic Stem Cell (hESC) Covered
Table Global Human Embryonic Stem Cell (hESC) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Human Embryonic Stem Cell (hESC) Market Size Market Share by Type 2014-2025
Figure Totipotent Stem Cell Figures
Table Key Players of Totipotent Stem Cell
Figure Pluripotent Stem Cell Figures
Table Key Players of Pluripotent Stem Cell
Figure Unipotent Stem Cell Figures
Table Key Players of Unipotent Stem Cell
Table Global Human Embryonic Stem Cell (hESC) Market Size Growth by Application 2014-2025 (Million US$)
Figure Research Case Studies
Figure Clinical Trials Case Studies
Figure Others Case Studies
Figure Human Embryonic Stem Cell (hESC) Report Years Considered
Table Global Human Embryonic Stem Cell (hESC) Market Size 2014-2025 (Million US$)
Figure Global Human Embryonic Stem Cell (hESC) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Size by Regions 2014-2025 (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Size by Regions 2014-2019 (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Share by Regions 2014-2019
Figure Global Human Embryonic Stem Cell (hESC) Market Share by Regions 2014-2019
Figure Global Human Embryonic Stem Cell (hESC) Market Share by Regions 2019
Table Market Top Trends
Table Global Human Embryonic Stem Cell (hESC) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Share by Manufacturers (2014-2019)
Figure Global Human Embryonic Stem Cell (hESC) Market Share by Manufacturers in 2018
Table Global Human Embryonic Stem Cell (hESC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Embryonic Stem Cell (hESC) Product/Solution/Service
Table Date of Enter into Human Embryonic Stem Cell (hESC) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Size Share by Type (2014-2019)
Figure Global Human Embryonic Stem Cell (hESC) Market Size Market Share by Type (2014-2019)
Table Global Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table Global Human Embryonic Stem Cell (hESC) Market Size Share by Application (2014-2019)
Figure Global Human Embryonic Stem Cell (hESC) Market Size Market Share by Application (2014-2019)
Figure Global Human Embryonic Stem Cell (hESC) Revenue Market Share by Application in 2018
Figure United States Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table United States Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table United States Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table United States Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table United States Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table United States Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table United States Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure Europe Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table Europe Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table Europe Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table Europe Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table Europe Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table Europe Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table Europe Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure China Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table China Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table China Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table China Human Embryonic Stem Cell (hESC) Market Size by Type (2014-20189) (Million US$)
Table China Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table China Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table China Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure Japan Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table Japan Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table Japan Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table Japan Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table Japan Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table Japan Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table Japan Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure Southeast Asia Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table Southeast Asia Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure India Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table India Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table India Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table India Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table India Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table India Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table India Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Figure Central & South America Human Embryonic Stem Cell (hESC) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human Embryonic Stem Cell (hESC) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human Embryonic Stem Cell (hESC) Market Share (2018-2019)
Table Central & South America Human Embryonic Stem Cell (hESC) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Human Embryonic Stem Cell (hESC) Market Share by Type (2014-2019)
Table Central & South America Human Embryonic Stem Cell (hESC) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Human Embryonic Stem Cell (hESC) Market Share by Application (2014-2019)
Table Astellas Institute of Regenerative Medicine (US) Company Details
Table Astellas Institute of Regenerative Medicine (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019) (Million US$)
Figure Astellas Institute of Regenerative Medicine (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Astellas Institute of Regenerative Medicine (US) Recent Development
Table Asterias Biotherapeutics, Inc. (US) Company Details
Table Asterias Biotherapeutics, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure Asterias Biotherapeutics, Inc. (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Asterias Biotherapeutics, Inc. (US) Recent Development
Table BD Biosciences (US) Company Details
Table BD Biosciences (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure BD Biosciences (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table BD Biosciences (US) Recent Development
Table Cell Cure Neurosciences Ltd. (Israel) Company Details
Table Cell Cure Neurosciences Ltd. (Israel) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure Cell Cure Neurosciences Ltd. (Israel) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Cell Cure Neurosciences Ltd. (Israel) Recent Development
Table Cellular Dynamics International (US) Company Details
Table Cellular Dynamics International (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure Cellular Dynamics International (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Cellular Dynamics International (US) Recent Development
Table GE Healthcare (UK) Company Details
Table GE Healthcare (UK) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure GE Healthcare (UK) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table GE Healthcare (UK) Recent Development
Table MilliporeSigma (US) Company Details
Table MilliporeSigma (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure MilliporeSigma (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table MilliporeSigma (US) Recent Development
Table PerkinElmer, Inc. (US) Company Details
Table PerkinElmer, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure PerkinElmer, Inc. (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table PerkinElmer, Inc. (US) Recent Development
Table Reliance Life Sciences Ltd. (India) Company Details
Table Reliance Life Sciences Ltd. (India) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure Reliance Life Sciences Ltd. (India) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Reliance Life Sciences Ltd. (India) Recent Development
Table Research & Diagnostics Systems, Inc. (US) Company Details
Table Research & Diagnostics Systems, Inc. (US) Revenue in Human Embryonic Stem Cell (hESC) Business (2014-2019)(Million US$)
Figure Research & Diagnostics Systems, Inc. (US) Revenue Growth Rate in Human Embryonic Stem Cell (hESC) Business (2014-2019)
Table Research & Diagnostics Systems, Inc. (US) Recent Development
Table SABiosciences Corp. (US) Company Details
Table STEMCELL Technologies, Inc. (Canada) Company Details
Table Stemina Biomarker Discovery, Inc. (US) Company Details
Table Takara Bio, Inc. (Japan) Company Details
Table TATAA Biocenter AB (Sweden) Company Details
Table Thermo Fisher Scientific, Inc. (US) Company Details
Table UK Stem Cell Bank (UK) Company Details
Table ViaCyte, Inc. (US) Company Details
Table Vitrolife AB (Sweden) Company Details
Table Global Human Embryonic Stem Cell (hESC) Market Size by Regions (Million US$) 2019-2025
Figure Global Human Embryonic Stem Cell (hESC) Market Size Share by Regions (2019-2025)
Figure Global Human Embryonic Stem Cell (hESC) Market Size Share by Regions in 2025
Figure United States Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure China Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure India Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human Embryonic Stem Cell (hESC) Market Size Forecast (2019-2025)(Million USD)
Table Global Human Embryonic Stem Cell (hESC) Market Size by Product (2019-2025) (Million US$)
Figure Global Human Embryonic Stem Cell (hESC) Market Size by Product (2019-2025)
Figure Global Human Embryonic Stem Cell (hESC) Market Size by Product in 2025
Table Global Human Embryonic Stem Cell (hESC) Market Size by Application (2019-2025) (Million US$)
Figure Global Human Embryonic Stem Cell (hESC) Market Size by Application (2019-2025)
Figure Global Human Embryonic Stem Cell (hESC) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources